A Long-term Follow-up Study of the Investigational GSK Biologicals' GSK3277511A Vaccine in Adults

Trial Profile

A Long-term Follow-up Study of the Investigational GSK Biologicals' GSK3277511A Vaccine in Adults

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 04 Oct 2017

At a glance

  • Drugs GSK 3277511 (Primary)
  • Indications Respiratory tract disorders
  • Focus Pharmacodynamics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 28 Sep 2017 Status changed from recruiting to active, no longer recruiting.
    • 24 Jul 2017 Status changed from not yet recruiting to recruiting.
    • 30 Jun 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top